#031: May 10th, 2021 - Longevity Marketcap Telemetry
Announcements
Last Week in Longevity
Longevity Futures
Capital Raise Radar
Longevity Jobs
New Companies on Longevity List
Thoughts on what the aging field needs
My Links
*Disclaimer: None of this should be taken as financial advice. It is for educational purposes only.
Mission: To grow a wave of passionate people building, funding, and championing technologies that extend healthy human lifespan.
If you want to be part of this mission alongside me, please consider supporting through Patreon or Longevity List Merch.
📢 Announcements
The Longevity Biotech Show is officially a podcast! Check us out on Spotify. Coming soon to Apple Podcasts, pending approval.
forum.longevitybase.org - I’m rolling out a “StackExchange / Quora” for aging biology / longevity biotech. It’s in open beta right now. Feel free to sign up and try it out. Email me if you would like to become a moderator or if you have some suggestions.
For academics, independent researchers, biotech founders, and scientific-minded enthusiasts.
Ask questions, get answers → builds a searchable longevity research knowledge base.
Every Friday @ 12PM - 5PM EDT. Longevity Virtual Coworking. If you are working on longevity or thinking about getting into the longevity industry, please join me for an experimental virtual longevity coworking space using the Pluto.Video web app. (No sign-up required.)
Bring something to work on.
Feel free to ask questions.
Help out. Connect.
I plan on holding this weekly. It’s free. (Room Link)
The 1% Bet for Longevity-- a website initiative. 36 people have now signed up for the 1% Bet for Longevity Pledge. My goal is to get to 50,000 people and at least 100 companies to pledge 1% of their resources towards funding longevity companies and research by the end of the year.
📝 Last Week in Longevity
Michael Greve announces 300M EUR to fund rejuvenation biotech startups. Michael Greve is the founder of Kizoo Technology Capital and the non-profit Forever Healthy Foundation. Last week Greve announced an additional 300M EUR to fund longevity biotechnology startups through Kizoo.
This is BIG news. To put the announcement into perspective, an average-sized longevity biotech seed round is around $5M, according to the longevitylist.com database. Greve’s capital can therefore seed an additional ~70 longevity startups on top of the 115 longevity startups on Longevity List. Note that the announced funding doesn’t account for the amount of external
This excerpt is provided for preview purposes. Full article content is available on the original publication.


